Ryan D. Maynard
Equibles does not estimate personal net worth.
Get an email with a short summary when Foghorn Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get FHTX alertsAbout Ryan D. Maynard
Ryan D. Maynard is recorded as CFO at Foghorn Therapeutics Inc. (FHTX) since February 23, 2026. Foghorn Therapeutics Inc. reported in an 8-K filed February 23, 2026 that Ryan D. Maynard was appointed Chief Financial Officer, effective February 23, 2026. Foghorn Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Foghorn Therapeutics Inc. includes Adrian Gottschalk (CEO and Board Member), Jeff Sacher (CFO), Kristian F. Humer (CFO and Chief Accounting Officer) and 7 others.
“On February 23, 2026, Foghorn Therapeutics Inc. (the "Company") announced that Ryan D. Maynard had been appointed to serve as the Company's Chief Financial Officer, effective immediately.”
Affiliation history
-
Current
2026-02-23–present
Company network
Leadership on record at Foghorn Therapeutics Inc.
- Adrian Gottschalk CEO, Board Member
- Jeff Sacher CFO
- Kristian F. Humer CFO, Chief Accounting Officer
- Ryan Maynard CFO
- Stephen J. DiPalma CFO
- Steven Bellon CTO
- B. Lynne Parshall Board Member
- Ian F. Smith Board Member
- Neil J. Gallagher, M.D., Ph.D. Board Member
- Stuart Duty Board Member